Delivery Order SPE2DB20D1109-SPE2DB23FQ00J
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,818.90, is for the delivery of Mitomycin 5 mg vials, a specialty cancer medication. The contract is a firm fixed-price, delivery order type with a completion date of May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,777 units of Mitomycin 5 mg vials, a chemotherapy medication. The contract has a firm fixed price of $2,751.36 and a completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,751.36 firm fixed-price contract is for the supply of 5 mg vials of the drug mitomycin. The contract has an ultimate completion date of January 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order (Contract #SPE2DB20D1100 | SPE2DB24FD9D4) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 5 mg Mitomycin vials. The award is valued at $2,977.68 and has a firm-fixed price. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $2,448 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mitomycin 40 mg vials, with completion targeted for September 16, 2025. This firm fixed-price contract is a non-set-aside award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The pharmaceutical will be...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of a variety of pharmaceutical products, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical supplies such as syringes, vials, and test kits. The delivery order, valued at $1,855.82, is for a specific medication,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,546.96, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,563.70, is for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract is a firm fixed-price delivery order issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,710.76, is for the delivery of various medical products and supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract is a firm fixed-price delivery order with an ultimate completion date of March 19, 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.60 contract is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FQ00JDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.95, is for the delivery of MITOMYCIN 20 MG VIALS, a specialty pharmaceutical product. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that broader IDC, enabling efficient government procurement of essential medical commodities. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/25/23 |